Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome
Open Access
- 22 September 2025
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , 656-664
Abstract
Context: Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with chronic inflammation, but comprehensive characterization of immune markers across diverse patient populations is lacking. Objective: To determine whether PCOS exhibits a profile of chronic inflammation or immune dysregulation when analyzed across a diverse patient population. Design: Retrospective cross-sectional study of samples collected between 1987 and 2010 as part of the Androgen Excess Biorepository. Setting: Reproductive endocrinology clinics at the University of Alabama at Birmingham in Birmingham, Alabama, and Cedars-Sinai Medical Center in Los Angeles, California, where women and adolescents presented for evaluation of androgen excess. Patients: Forty premenopausal women (20 with PCOS, 20 controls) aged 18 to 45 years, categorized by race (Black and White) and PCOS diagnosis. Participants were race, age, and body mass index matched. Main Outcome Measures: Fasted follicular phase plasma concentrations of C-reactive protein and 96 circulating immune markers, including interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-18, measured using a Milliplex Luminex xMAP assay. Results: PCOS patients showed significantly lower levels of circulating immune markers (P < .05). Growth factors (vascular endothelial growth factor A, platelet-derived growth factor), proinflammatory cytokines (IL-8, TNF-α, interferon-γ), and several chemokines were reduced in PCOS patients, independent of race. Only IL-18 and C-X-C motif chemokine ligand 16 showed statistically significant differences between Black and White women. Conclusion: This study challenges the prevailing notion of PCOS as a disorder of chronic low-grade inflammation, suggesting instead that immune suppression and impaired angiogenic signaling may be factors in PCOS pathophysiology, especially in nonobese patients. Further research with larger sample sizes and inclusion of metabolic metrics is needed to confirm these findings before they can be applied in clinical practice.Keywords
Funding Information
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R00 HD098330)
- Diabetes and Digestive and Kidney Diseases (U24DK132746)
- UCLA LIFT-UP
This publication has 34 references indexed in Scilit:
- Incident racial discrimination predicts elevated C-Reactive protein in the Black Women’s experiences Living with Lupus (BeWELL) studyBrain, Behavior, and Immunity, 2023
- Racial and ethnic disparities in polycystic ovary syndromeFertility and Sterility, 2023
- The hallmark of pro- and anti-inflammatory cytokine ratios in women with polycystic ovary syndromeCytokine, 2020
- Role of IL-6 signalling in Polycystic Ovarian Syndrome associated inflammationJournal of Reproductive Immunology, 2020
- IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilizationJournal of Reproductive Immunology, 2020
- Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndromeJournal of Cellular Physiology, 2018
- Suppressive effects of androgens on the immune systemCellular Immunology, 2015
- Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United StatesMaturitas, 2012
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Hirsutism: Implications, etiology, and managementAmerican Journal of Obstetrics and Gynecology, 1981